Entourage AI
London, United Kingdom· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An AI-driven drug discovery company using machine learning to identify novel targets and design new therapeutics.
OncologyNeuroscience
Technology Platform
A proprietary AI platform that integrates deep learning with biomedical knowledge graphs to predict novel drug targets and generate optimized molecular structures.
Opportunities
The massive and growing demand for efficiency in R&D creates a strong market for AI tools that can reduce costs and failure rates in early discovery.
Risk Factors
Key risks include the unproven translational success of AI-generated candidates and potential algorithmic biases leading to clinical failures.
Competitive Landscape
It competes in a crowded field of AI-driven discovery firms like Exscientia, Recursion, and BenevolentAI, where differentiation depends on platform validation and successful partnerships.